Find your path to Eric
250 people in our graph share verified history with Eric β schools, employers, funds. One of them is your warm intro.
Noubar AfeyanunlockedEric: together at Moderna (2012β2024)
Eric: together at Moderna
Eric: together at Alnylam
Γ9Eric: together at Questrom School of Business, Boston University
About
Eric Huang joined Delos Capital as a Senior Advisor in 2020, became an Operating Partner, and transitioned to full-time Partner in 2024. He previously held leadership roles at Moderna Therapeutics, including founding CSO of New Venture Labs, where he conceived the mRNA vaccine platform, and later served as GM and CSO at Moderna Genomics.
ContactΒ· self-published, not guessed
Invests in
Biotech
Experience
- Delos CapitalPartnercurrent2024 β presentBoston, Massachusetts, United States
- Delos CapitalOperating Partner2022 β 2024
- TAIGEN BioscienceIndependent Directorcurrent2025 β present
- TRexBioBoard Membercurrent2024 β presentSan Francisco Bay Area
- Averna TherapeuticsBoard Observercurrent2024 β present
- ModernaGM/CSO, Moderna Genomics2020 β 2024United States
- ModernaCSO, Autoimmune and Inflammation2019 β 2021Cambridge, Massachusetts, United States
- ModernaChief Scientific Officer, New Venture Labs2017 β 2019Cambridge, MA
- ModernaHead, New Venture Labs and Biologics Discovery2016 β 2017Cambridge MA
- ModernaHead, New Venture Labs2014 β 2017Cambridge, MA
- ModernaSenior Director, Strategy and Business Development2012 β 2014Cambridge, MA
- Seaside TherapeuticsDirector of Business Development2010 β 2012
- Alnylam PharmaceuticalsBusiness Development Consultant2010
- StromedixAssociate Director, Corporate Development and Planning2007 β 2010
- DomantisSenior Manager, Business Development2003 β 2007
Skills & more
Start-ups26Drug Discovery15Drug Development12Biotechnology30Biopharmaceuticals20New Business Development6Business Strategy6Portfolio Management5Licensing8Contract Negotiation3Infectious Diseases14Strategy12
+10 more
OncologyLife SciencesMonoclonal AntibodiesMarket ResearchPatentsMolecular BiologyPharmaceutical IndustryVenture CapitalCompetitive IntelligenceClinical DevelopmentLanguages Chinese (Mandarin)
From Eric's professional profile.
Colleagues at Delos Capital
Adolfo Pena
Director at Delos Capital
Agnes Kwok
Financial Controller at Delos Capital
Andrea Lok
Executive Assistant at Delos Capital
Carrie Greenaway
Office Manager at Delos Capital
Dawn Griffiths
Director at Delos Capital
Faris Lodin
Managing Director at Sterling Equity
Hank Huang
Associate at Delos Capital
Henry Chen
Managing Partner at Delos Capital
Frequently asked questions
- Who is Eric Huang?
- Eric Huang joined Delos Capital as a Senior Advisor in 2020, became an Operating Partner, and transitioned to full-time Partner in 2024. He previously held leadership roles at Moderna Therapeutics, including founding CSO of New Venture Labs, where he conceived the mRNA vaccine platform, and later served as GM and CSO at Moderna Genomics.
- Where does Eric Huang work?
- Eric Huang is Partner, Ph.D. at Delos Capital.
- What does Eric Huang invest in?
- Eric Huang invests in Biotech.
- Where did Eric Huang go to school?
- Eric Huang studied at New York University (PhD, Molecular and Medical Parasitology); Questrom School of Business, Boston University (MBA); Emory University (BS, Biology).
Same school
Also attended New York University722
Jonathan RossFounder of Groq; inventor of Google's TPU β now at NvidiaGabriella GiglioHR & Executive Talent at General CatalystAndrea EchstenkamperVP of Marketing at HeavybitRami BranitzkyPartner at Sapphire VenturesZach WhiteInvestment Team at 8VCAnkita TiwariPrograms Manager at StartX
+ 716 more
Also attended Questrom School of Business, Boston University183
Sujata BhatiaInvestor at Index VenturesTroy PhoaAssociate at Marlin Equity PartnersGlen BressnerCo-Founder and Managing Partner at Activate Venture PartnersRony Patishi-ChillimInvestor at Israel Cleantech VenturesJason RobartCo-founder and General Partner at Seae VenturesLisa DutotFinance Administration Manager at Red Cell Incubation
+ 177 more
Also attended Emory University234
William HockeyCo-founder of Plaid; founder & CEO of ColumnDave MunichielloInvestor at GV (Google Ventures)Ryan HaysBoard Member at CincyTechJustin RobenyAssociate at Osage University PartnersZitong SuAssociate at Marlin Equity PartnersGurbani SinghPrincipal - Investor Relations at Marlin Equity Partners
+ 228 more
Also attended Bard College at Simon's Rock14
Jessica MahCo-Founder & Executive Chair, InDinero at xfactor venturesNoah SavolainenAnalyst at Bain Capital Tech OpportunitiesLaurent RainsManaging Director, Alchemist Platform at Alchemist JapanYoungro LeeVenture Advisor at Mercury FundDerek WalkerManaging Director at Gallatin Point CapitalCarly PriceFounder at Liv Labs
+ 8 more
Shared employers
Also worked at TRexBio8
Susannah BarbeeVice President, Translational Immunology at Deerfield Management CompanyAlexandra CantleyManaging Partner at Polaris PartnersNikolaInvestment Committee Member at ACF InvestorsNikola TrbovicManaging Partner at SV Health InvestorsAlex Badamchi-ZadehVice President at SV Health InvestorsDr. Jeanne BolgerAdvisor at Apollo Health Ventures
+ 2 more
Also worked at Averna Therapeutics5
Also worked at Moderna31
Dave JohnsonCo-founder & CEO of Dash BioNoubar AfeyanInvestor at Flagship PioneeringGisella de la RochaVice President of Legal at MPM BioImpactAxel BouchonVenture Partner at ARCH Venture PartnersJordan SilvaCampus Lead at The MBA FundLee CooperManaging Director at Delos Capital
+ 25 more
Also worked at Alnylam Pharmaceuticals19
Bret L. BostwickMD, FAAP, FACMG, Venture Advisor at Breyer CapitalJason RhodesPartner at Atlas VentureJohn MaraganoreAdvisor at Oak HC/FTVincent MilesExecutive Director at AbingworthJohn ConleyBoard Member at Launchpad Venture GroupArmand CognettaFounder at General Proximity
+ 13 more























































